Pluri Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pluri Inc. on February 6, 2023. The filing addresses Item 5.08 regarding Shareholder Director Nominations and the scheduling of the 2023 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial performance data.
Material Changes
The primary material change is the rescheduling of the 2023 Annual Meeting of Stockholders. The meeting is now set for April 20, 2023, at 5:00 p.m. Israel time, at the Company's office in Haifa, Israel. This date differs by more than thirty days from the anniversary of the 2022 Annual Meeting (June 21, 2022), rendering previous deadlines for stockholder proposals under Rule 14a-8 inapplicable.
Guidance, Outlook, and Deadlines
- Annual Meeting Date: Thursday, April 20, 2023.
- Record Date: February 27, 2023 (close of business).
- Proposal Deadline: Stockholder proposals for inclusion in proxy materials must be received by February 15, 2023.
- Submission Contact: Proposals should be sent to Chen Franco Yehuda, CFO and Secretary, via mail or email to investor.relations@pluri-biotech.com.
Key Facts for Investor Verification
- Verify the new Annual Meeting date of April 20, 2023, and the record date of February 27, 2023.
- Confirm the February 15, 2023 deadline for submitting stockholder proposals or director nominations.
- Note that the filing does not contain financial results or operational updates.